2021 New Updates: China NMPA Medical Device Clinical Pathways

2021 New Updates: China NMPA Medical Device Clinical Pathways

  • Version
  • 19 Download
  • 0.00 KB File Size
  • 1 File Count
  • January 27, 2021 Create Date
  • April 8, 2021 Last Updated
  • Subscribe To Watch

Want to reduce your device’s clinical trial costs and accelerate its time to market in China? It’s possible when you use the latest China National Medical Products Administration (NMPA) regulatory developments to your advantage.

Now more than ever, NMPA’s regulatory approval process is going through transformational reform. Device makers — especially non-China manufacturers — have more options to supplement the traditional comprehensive clinical trial.


File
ojClmkc1 xA